glp 1 magic Patients on GLP-1s: Drugs Aren't a 'Magic Bullet' GLP-1 Support Supplement for Appetite

Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets

The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising

At Viome, we believe that understanding your unique biologyincluding your gut microbiomeis the key to unlocking optimal metabolic health

Health experts say more research is needed to understand the connection

Take the First Step Towards a Healthier You This No Smoking Day, we encourage you to take that courageous first step